MT 1717 Allylaminogeldanamycin, [allylamino-2,3-3H]- |
|
| (17-AAG, [allylamino-2,3-3H]-) | |
| Ethanol solution, 250 µCi/ml | 50 μCi (1.85 MBq) $1160 |
| > 10 Ci(0.37 TBq)/mmolor below | 250 μCi (9.25 MBq) $1970 |
| NextGen V-Vial - shipped on dry ice | |
|
M.W. 585.7  |
|
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |